Evidence map›Paper›PMID 25193664›Full record

ArticleThe Journal of biological chemistry2014

The catabolite control protein E (CcpE) affects virulence determinant production and pathogenesis of Staphylococcus aureus.

Torsten Hartmann, Grégory Baronian, Nadine Nippe, Meike Voss, Bettina Schulthess, Christiane Wolz, Janina Eisenbeis, Kerstin Schmidt-Hohagen, Rosmarie Gaupp, Cord Sunderkötter and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of sodium salicylate inFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Virulence and Metabolism.Microbiology spectrum · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. CcpA Affects Infectivity ofFrontiers in cellular and infection microbiology · 2017
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Torsten HartmannFrom the Institute of Medical Microbiology and Hygiene, University of Saarland, 66421 Homburg/Saar, Germany.
Grégory Baronianthe Laboratoire de Dynamique des Interactions Membranaires Normales et Pathologiques, Université Montpellier 2, CNRS, UMR 5235, 34090 Montpellier, France.
Nadine Nippethe Institute of Immunology, University of Münster, 48149 Münster, Germany.
Meike Vossthe Department of Internal Medicine V-Pulmonology, Allergology and Critical Care Medicine, Saarland University Medical Centre, 66421 Homburg/Saar, Germany.
Bettina Schulthessthe Institute of Medical Microbiology, University of Zürich, 8006 Zürich, Switzerland.
Christiane Wolzthe Institute of Medical Microbiology and Hygiene, University Hospital of Tübingen, 72076 Tübingen, Germany.
Janina EisenbeisFrom the Institute of Medical Microbiology and Hygiene, University of Saarland, 66421 Homburg/Saar, Germany.
Kerstin Schmidt-Hohagenthe Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, 38106 Braunschweig, Germany.
Rosmarie GauppFrom the Institute of Medical Microbiology and Hygiene, University of Saarland, 66421 Homburg/Saar, Germany.
Cord Sunderkötterthe Department of Dermatology, University of Münster, 48149 Münster, Germany, and.
Christoph Beisswengerthe Department of Internal Medicine V-Pulmonology, Allergology and Critical Care Medicine, Saarland University Medical Centre, 66421 Homburg/Saar, Germany.
Robert Balsthe Department of Internal Medicine V-Pulmonology, Allergology and Critical Care Medicine, Saarland University Medical Centre, 66421 Homburg/Saar, Germany.
Greg A Somervillethe School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583-0903.
Mathias HerrmannFrom the Institute of Medical Microbiology and Hygiene, University of Saarland, 66421 Homburg/Saar, Germany.
Virginie Mollethe Laboratoire de Dynamique des Interactions Membranaires Normales et Pathologiques, Université Montpellier 2, CNRS, UMR 5235, 34090 Montpellier, France.
Markus BischoffFrom the Institute of Medical Microbiology and Hygiene, University of Saarland, 66421 Homburg/Saar, Germany, markus.bischoff@uks.eu.
University of Münster · DEInstitute of Medical Microbiology and Hygiene · DEUniversity of Zurich · CH

Funding

Citric acid cycle regulation of exopolysaccharide synthesis in staphylococciR01AI087668 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI SOMERVILLE, GREG ALAN · 2010 to 2013
$1.4M
NIAID NIH HHS AI087668NIAID NIH HHS R01 AI087668
6 · The paper itself

Abstract

Carbon metabolism and virulence determinant production are often linked in pathogenic bacteria, and several regulatory elements have been reported to mediate this linkage in Staphylococcus aureus. Previously, we described a novel protein, catabolite control protein E (CcpE) that functions as a regulator of the tricarboxylic acid cycle. Here we demonstrate that CcpE also regulates virulence determinant biosynthesis and pathogenesis. Specifically, deletion of ccpE in S. aureus strain Newman revealed that CcpE affects transcription of virulence factors such as capA, the first gene in the capsule biosynthetic operon; hla, encoding α-toxin; and psmα, encoding the phenol-soluble modulin cluster α. Electrophoretic mobility shift assays demonstrated that CcpE binds to the hla promoter. Mice challenged with S. aureus strain Newman or its isogenic ΔccpE derivative revealed increased disease severity in the ΔccpE mutant using two animal models; an acute lung infection model and a skin infection model. Complementation of the mutant with the ccpE wild-type allele restored all phenotypes, demonstrating that CcpE is negative regulator of virulence in S. aureus.

Indexed as

AnimalsBacterial CapsulesBacterial ProteinsDisease Models, AnimalFemaleGene DeletionLungMice, Inbred C57BLModels, BiologicalMultigene FamilyPigments, BiologicalRNA, BacterialStaphylococcal InfectionsStaphylococcus aureusTranscription, GeneticVirulenceBacterial ProteinsPigments, BiologicalRNA, BacterialRNAIII, Staphylococcus aureusVirulence FactorsBacterial PathogenesisStaphylococcus aureus (S. aureus)Transcription RegulationTricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle)Virulence Factor

Identifiers

PMID25193664
PMCPMC4207984
OpenAlexW2112878597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.